Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Total Non-Current Liabilities (2019 - 2021)

Pliant Therapeutics (PLRX) has disclosed Total Non-Current Liabilities for 3 consecutive years, with $22.2 million as the latest value for Q4 2021.

  • Quarterly Total Non-Current Liabilities rose 91.02% to $22.2 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $22.2 million through Dec 2021, up 91.02% year-over-year, with the annual reading at $22.2 million for FY2021, 91.02% up from the prior year.
  • Total Non-Current Liabilities for Q4 2021 was $22.2 million at Pliant Therapeutics, up from $12.9 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $22.2 million in Q4 2021, with the low at $8.2 million in Q4 2019.
  • Average Total Non-Current Liabilities over 3 years is $12.6 million, with a median of $11.6 million recorded in 2020.
  • Peak annual rise in Total Non-Current Liabilities hit 91.02% in 2021, while the deepest fall reached 15.78% in 2021.
  • Over 3 years, Total Non-Current Liabilities stood at $8.2 million in 2019, then skyrocketed by 41.94% to $11.6 million in 2020, then soared by 91.02% to $22.2 million in 2021.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $22.2 million, $12.9 million, and $10.9 million for Q4 2021, Q3 2021, and Q2 2021 respectively.